medic
ro
cardio
sigur şi fezabil; întârzierea a fost nu atinge pragul semnificaţiei sta- Concluzii
de 85 min.; s-a obţinut reducerea tistice decât la pacienţii a dresaţi n Dezobstrucţia coronariană cât
semnificativă a reinfarctizării la peste 3 ore de la debut; mai precoce îmbunătăţeşte sem-
(p = 0,03) şi a end-point-ului com- n DANAMI 2: transferul pacien- nificativ prognosticul IMA.
binat (p <0,02); ţilor în vederea realizării an- n Beneficiile angioplastiei primare
n AIR-PAMI: pacienţii cu risc cres- gioplastiei primare este indicat, cu stent sunt superioare trom-
cut au beneficiu ca urmare a rezultatele fiind superioare trom- bolizei, transferul pacienţilor că-
trans portului în vederea PTCA pri- bolizei, mai ales în cazurile în care tre centrele medicale cu unităţi
mară (reducerea ratei deceselor, durata transportului este sub 120 de cardiologie intervenţională
reinfarctizării, AVC); min. (reducerea re infarctizării - fiind indicat mai ales atunci
n PRAGUE 2: transferul pacientului p <0,0001 şi a end-point-ului când durata transportului este
este sigur; reducerea mortalităţii c o m binat - p <0,003). sub 120 de minute. n
Bibliografie
1. Simons-Morton D.G., Goff D.C., Osganian S. et al. for the REACT. 17. Grines C.L., Marsalese D.L., Brosie B.R. et al. for the PAMI-II in-
Researche Group, Rapid early action for coronary treatment: ratio- vestigators. Safety and cost-effectiveness of early discharge after
nale design, and baseline caracteristics, A. Cod. Emerg., Med 1998; primary angioplasty in low risk patients with acute myocardial in-
5: 726-738. farction. J Am Coll Cardiol, 1998; 31:967-972.
2. Gibler W.B., Gore J.M., Weaver W.D. For the GUSTO-III Investiga- 18. Zijlstra F., de Boer M.J., Hoorntje J.C.A. et al. A comparison
tors. Reduced time of thrombolytic delivery, but statistic time to of immediate coronary angioplasty with intravenous strep-
prezentation: the GUSTO experience from 1990 to 1997(abstr.), Cir- tokinase in acute myocardial infarction. N Engl J Med, 1993;
culation, 1997; 96, Suppl. I: I-201. 328:640-644.
3. Gruppo Italiano per la Studio della Streptochinesi nell’infarto mio- 19. The Global Use Strategies to Open Occluded Coronary Ar-
cardico (GISSI-1) Long-terms effects of intravenous thrombolysis in teries in Acute Coronary Syndromes (GUSTO IIb)Angioplasty Sub-
acute myocardial infarction: final report of the GISSI study, Lancet, study Investigators. A Clinical trial comparing primary coronary
1986; 1: 397-401. angioplasty with tissue plasminogen activator for acute myocardial
4. Căpâlneanu R. Angioplastia primară în IMA. Posibilităţi şi limite. infarction. N Engl J Med, 1997; 336:1.621-1.628.
În: Gherasim L. Progrese în cardiologie, Ed INFO Medica, Bucureşti, 20. Weaver W.D., Simes R.J., Betriu A. et al., Comparison of primary
2002, 145-164. coronary angioplasty and intravenous thrombolytic therapy for
5. Zijlstra F. Acute myocardial infarction: Primary angioplasty. Heart, acute myocardial infarction: a quantitative review. JAMA, 1997;
2001, 85:705-709. 278:2093-2098.
6. Topol E.J. Comprehensive cardiovascular medicine, vol. 1, Lippin- 21. Grines C., Browne K., Marco J. et al. A comparison of immediate
cott-Raven Publishers, 1998, 425-509. angioplasty with thrombolytic therapy for acute myocardial in-
7. Hartzler G.O., Rutherford B.D., Mc Conahay D.R. Percutaneous farction. The Primary Angioplasty in Myocardial Infarction Study
transluminal coronary angioplasty: Application for acute myocar- Group, N Engl J Med, 1993, 328, 673-679.
dial infarction. Am J Cardiol 1984; 53:117C-121C. 22. Zijlstra F., de Boer M.J., Beukema W. et al. Mortality, reinfarction,
8. The GUSTO Investigators. An international randomised trial com- left ventricular ejection fraction and costs following reperfusion
parind four thrombolytic strategies for acute myocardial infarction, therapies for acute myocardial infarction, Eur Heart J., 1996, 17,
N. Engl. J. Med, 1993, 329, 673. 382-387.
9. Chesebro J., Knatterud G., Roberts R. et al., Thrombolysis in myo- 23. Dauerman H.L., Goldberg R.J., White K. et al. Global use of revas-
cardial infarction(TIMI) trial, phase I: A comparisson between in- cularization for patients in cardiogenic shock: findings from the
travenous tissue plasminogen activator and intravenous streptoki- Global Registry of Acute Coronary Events(GRACE), Circulation,
nase, Circulation, 1987, 76, 142. 2001; 104(suppl.2), 2205.
10. Hudson M., Granger C., Topol E. et al. Early reinfarction after fi- 24. Zahn R., Schiele R., Gitt A. et al. Impact of prehospital delay on
brinoliysis: experience from the global utilisation of streptokinase mortality in pacients with acute myocardial infarction treated with
and tissue plasminogen activator(alteplase) for occluded coronary primary angioplasty and intravenous thrombolysis, Am. Heart J.,
arteries (GUSTO I) and global use of strategies to open occluded 2001, 142, 105.
coronary artery(GUSTO III) trials, Circulation, 2001, 104, 1229. 25. Liem A. et al. Influence of treatment delay on infarct size and clini-
11. Ellis S. et al. Treatment of recurent ischemia after thrombolysis cal outcome in patients with acute myocardial infarction treated
and successful reperfusion for acute myocardial infarction: effect with primary angioplasty, J. Am. Coll. Cardiol, 1998, 32, 629.
on in-hospital mortality and left ventricular function, J. Am. Coll. 26. Sheiban I., Fragasso G., Lu C. et al. Influence of treatment delay on
Cardiol,1991, 17, 752-757. long-term ventricular function in patients with acute myocardial
12. Muller D., Topol E., Ellis S. et al. Determinants of the need for early infarction successfully treated with primary angioplasty, Am. Heart
acute intervention in patients treated conservatively after throm- J., 2001, 141, 603.
bolytic therapy for acte myocardial infarction: TAMI-5 Study Group, 27. Sheiban I., Fragasso G., Rosano G. et al. Time course and determi-
J. Am. Coll. Cardiol, 1991, 18, 1594-1601. nants of left ventricular function recovery after primary angioplasty
13. Califf R., Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons in patients with acute myocardial infarction, J. Am. Coll. Cardiol,
from the SPEED and GUSTO IV trials, Am Heart J., 1999, 138, S12-S15. 2001, 38, 464.
14. Stone G., Grines C. Primary coronary angioplasty in acute myocar- 28. Zijlstra F., Patel A., Jones M. et al. Clinical characteristics and out-
dial infarction: comparative analysis with thrombolytic therapy.In: come of pacients with early (<2 h), intermediate (2-4 h) and late (>4
Stack R., Roubin G., O’Neill W., eds., Interventional cardiovascular h) presentation treated by primary coronary angioplasty or throm-
medicine. New York: Churchill Livingstone, 2002, 227-301. bolytic therapy for acute myocardial infarction, Eur Heart J, 2002,23,
15. Hazler G., Rutherford B., McConahay D. et al. Percutaneous transluminal 550-557.
coronary angioplasty with or without thrombolytic therapy for treatment 29. Kim C., Braunwald E. Potential benefits of later reperfusion in in-
of acute myocardial infarction, Am Heart J., 1983, 106, 965-973. farcted myocardium. The open artery hypothesis, Circulation, 1993,
16. Darie A.P., Mc Murray I.V. Cost-effectiveness of invasive strategy 88, 2426-2436.
in unstable coronary artery disease-what are we waiting for? Eur 30. Georgescu G.I.M., Arsenescu C. Tratamentul raţional al bolilor car-
Heart J., 2002; 23:1. diovasculare majore, Ed. Polirom, Iaşi, 2001.
pag. 92 nr. 51/februarie 2009
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100